Browse studies
Find your next paid study
100 recruiting studies matching your filters
Phase 1
A Phase 1, Multicenter, Open-label, Dose-escalation Study Evaluating the Safety and Tolerability of Intravenous KK2269 Monotherapy and Combination Therapy With Docetaxel in Adult Participants With Solid Tumors
This is a first-in-human study of KK2269. Part 1 and Part 2 will be conducted as a multicenter, open-label, non-randomized, dose-escalation study. Participants…
Advanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more
Estimated
~$10 – $8,750
Kyowa Kirin Co., Ltd.NCT06266299
PROPHETIC Extended - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Extended Study.
The goal of this exploratory study is understand the mechanisms of response to immunotherapy in Non-Small Cell Lung Cancer patients. The investigators are goi…
Non Small Cell Lung CancerHealthy
Estimated
~$10 – $1,050
OncoHost Ltd.NCT05736029
Phase 1
FIH Phase 1A /1B Study of AG01 Antibody Against Progranulin/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and Mesothelioma
This is a first in human phase 1 study of AG01 an anti-Progranulin/Glycoprotein88 (PGRN/GP88) antibody in patients with advanced solid tumors. AG01 is a recomb…
Triple Negative Breast CancerHormone-Resistant Breast CancerNon Small Cell Lung Cancer+1 more
Estimated
~$10 – $8,750
A&G Pharmaceutical Inc.NCT05627960
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical tria…
Cancer, MetastaticCancerCancer of Pancreas+40 more
Estimated
~$10 – $1,050
Massive Bio, Inc.